肠道细菌对药物的代谢

K. Kobashi, T. Akao, M. Hattori, T. Namba
{"title":"肠道细菌对药物的代谢","authors":"K. Kobashi, T. Akao, M. Hattori, T. Namba","doi":"10.12938/BIFIDUS1982.11.1_9","DOIUrl":null,"url":null,"abstract":"Food and drugs orally administered come inevitably in contact with intestinal bacterial flora in gut. The components in food and drugs are digested in the gut and absorbed from the alimentary tract via portal vein and then metabolized or detoxicated in the liver. Thereafter a part of metabolites are excreted into intestine via bile duct and meet again intestinal bacteria. Not only exogeneous substances but also endogenous ones once excreted in the bile come in contact with intestinal bacterial flora. Drugs administered intravenously, intramuscularly or intracutaneously also have chance to meet with intestinal bacteria when once excreted in the bile. Therefore, microflora in the gastrointestinal flora play significant roles in the enterohepatic circulation of drugs and food components. Accordingly, studies on the metabolism of drugs with intestinal microflora are important for research and development of medicines. However, such metabolic studies are very seldom, compared with the studies with liver, kidney, lung and other organs, because of huge numbers and species of anaerobic bacteria and for lack of biochemical studies on anaerobes. Intestinal bacterial flora are an environmental large factor in the body and almost equal to liver in weight and function, though their activities are mostly unknown. Recently, isolation, cultivation and identification techniques of intestinal bacteria from humans and experimental animals have been established. Therefore, metabolisms of food components and drugs with intestinal bacteria are able to be undertaken, based on biochemical and molecular biological backgrounds.","PeriodicalId":414713,"journal":{"name":"Bifidobacteria and Microflora","volume":"43 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"30","resultStr":"{\"title\":\"Metabolism of Drugs by Intestinal Bacteria\",\"authors\":\"K. Kobashi, T. Akao, M. Hattori, T. Namba\",\"doi\":\"10.12938/BIFIDUS1982.11.1_9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Food and drugs orally administered come inevitably in contact with intestinal bacterial flora in gut. The components in food and drugs are digested in the gut and absorbed from the alimentary tract via portal vein and then metabolized or detoxicated in the liver. Thereafter a part of metabolites are excreted into intestine via bile duct and meet again intestinal bacteria. Not only exogeneous substances but also endogenous ones once excreted in the bile come in contact with intestinal bacterial flora. Drugs administered intravenously, intramuscularly or intracutaneously also have chance to meet with intestinal bacteria when once excreted in the bile. Therefore, microflora in the gastrointestinal flora play significant roles in the enterohepatic circulation of drugs and food components. Accordingly, studies on the metabolism of drugs with intestinal microflora are important for research and development of medicines. However, such metabolic studies are very seldom, compared with the studies with liver, kidney, lung and other organs, because of huge numbers and species of anaerobic bacteria and for lack of biochemical studies on anaerobes. Intestinal bacterial flora are an environmental large factor in the body and almost equal to liver in weight and function, though their activities are mostly unknown. Recently, isolation, cultivation and identification techniques of intestinal bacteria from humans and experimental animals have been established. Therefore, metabolisms of food components and drugs with intestinal bacteria are able to be undertaken, based on biochemical and molecular biological backgrounds.\",\"PeriodicalId\":414713,\"journal\":{\"name\":\"Bifidobacteria and Microflora\",\"volume\":\"43 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bifidobacteria and Microflora\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12938/BIFIDUS1982.11.1_9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bifidobacteria and Microflora","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12938/BIFIDUS1982.11.1_9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

摘要

口服食物和药物不可避免地与肠道菌群接触。食物和药物中的成分在肠道内消化,经门静脉从消化道吸收,然后在肝脏代谢或解毒。随后,一部分代谢物经胆管排出肠内,与肠道细菌再次相遇。胆汁中不仅有外源性物质,也有内源性物质与肠道菌群接触。静脉、肌肉或皮内给药的药物一旦进入胆汁排泄,也有机会与肠道细菌相遇。因此,胃肠道菌群中的微生物在药物和食物成分的肠肝循环中起着重要的作用。因此,研究药物在肠道菌群中的代谢对药物的研究和开发具有重要意义。然而,与肝、肾、肺等器官的代谢研究相比,由于厌氧菌数量庞大、种类繁多,且缺乏厌氧菌的生化研究,对厌氧菌的代谢研究很少。肠道菌群是人体的一个重要环境因素,其重量和功能几乎与肝脏相当,尽管它们的活动大多是未知的。近年来,建立了人体和实验动物肠道细菌的分离、培养和鉴定技术。因此,基于生物化学和分子生物学背景,肠道细菌可以进行食物成分和药物的代谢。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Metabolism of Drugs by Intestinal Bacteria
Food and drugs orally administered come inevitably in contact with intestinal bacterial flora in gut. The components in food and drugs are digested in the gut and absorbed from the alimentary tract via portal vein and then metabolized or detoxicated in the liver. Thereafter a part of metabolites are excreted into intestine via bile duct and meet again intestinal bacteria. Not only exogeneous substances but also endogenous ones once excreted in the bile come in contact with intestinal bacterial flora. Drugs administered intravenously, intramuscularly or intracutaneously also have chance to meet with intestinal bacteria when once excreted in the bile. Therefore, microflora in the gastrointestinal flora play significant roles in the enterohepatic circulation of drugs and food components. Accordingly, studies on the metabolism of drugs with intestinal microflora are important for research and development of medicines. However, such metabolic studies are very seldom, compared with the studies with liver, kidney, lung and other organs, because of huge numbers and species of anaerobic bacteria and for lack of biochemical studies on anaerobes. Intestinal bacterial flora are an environmental large factor in the body and almost equal to liver in weight and function, though their activities are mostly unknown. Recently, isolation, cultivation and identification techniques of intestinal bacteria from humans and experimental animals have been established. Therefore, metabolisms of food components and drugs with intestinal bacteria are able to be undertaken, based on biochemical and molecular biological backgrounds.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信